Day 1: Oct 15, 2025
Day 2: Oct 15, 2025
2:30 pm
CASE STUDY: NAVIGATING THE ULTRA-NICHE
TRACK B: EMERGING, RARE, & SPECIALIST BRANDS
Targeted Marketing Strategies for Rare Disease Therapies
Rare disease therapies, like any niche area, require a specialized and personalized marketing approach. Source best practices on:
- Identifying and engaging small, dispersed patient populations.
- Building trust with patient advocacy groups and HCP key opinion leaders.
- Overcoming awareness and diagnostic challenges in rare diseases.
Develop your strategies for ultra rare drug marketing.
3:00 pm
CASE STUDY
TRACK B: EMERGING, RARE, & SPECIALIST BRANDS
Patient-Centric Commercial Models for Rare and Specialty Pharma
Bolster your commercial strategy by understanding the ongoing needs of specialty and rare disease patients and how to meet them. Develop a roadmap to:
- Enhancing patient access with innovative hub services and digital tools.
- Personalized patient support programs for long-term adherence.
- Real-world evidence and its impact on commercialization in rare diseases.
Optimize your rare and specialty branding with RWE and patient-focused information.
3:30 pm
INDUSTRY EXPERT
TRACK B: EMERGING, RARE, & SPECIALIST BRANDS
Holistic Patient Engagement Frameworks: A Comprehensive Approach to Inclusion
Patient feedback and inclusion is critical to the long-term success of drug development. Benchmark your strategies on:
- Implementing frameworks that integrate patient needs throughout the drug development process.
- Building methods for consistent assessment and planning for patient inclusion.
- Gaining insights from applying patient engagement frameworks in rare disease contexts.
Put rare disease patients first with patient-centred engagement frameworks.
